BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14678374)

  • 1. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.
    Manikandan R; Srirangam SJ; O'Reilly PH; Collins GN
    BJU Int; 2004 Jan; 93(1):84-8. PubMed ID: 14678374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency management of acute urinary retention: results from an all-Ireland urologist practice survey.
    Cullen IM; Dowling CM; Thornhill JA; Grainger R
    Ir J Med Sci; 2013 Jun; 182(2):207-11. PubMed ID: 23096424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study.
    Pandit RK; Agrawal CS; Chalise PR; Sapkota G
    Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
    Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
    Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis on management of acute urinary retention.
    Yoon PD; Chalasani V; Woo HH
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questionnaire survey of urologists' initial treatment practices for acute urinary retention secondary to benign prostatic hyperplasia in Korea.
    Ku JH; Kim SW; Paick JS
    Urol Int; 2006; 76(4):314-20. PubMed ID: 16679832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
    Bhomi KK; Bhattachan CL
    Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with a successful trial without catheter, after treatment with an alpha-adrenergic receptor blocker for acute urinary retention caused by benign prostatic hyperplasia.
    Lo KL; Chan MC; Wong A; Hou SM; Ng CF
    Int Urol Nephrol; 2010 Mar; 42(1):7-12. PubMed ID: 19449121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha-adrenergic blockers as a support in the treatment of acute urinary retention].
    Altarac S
    Lijec Vjesn; 2006; 128(7-8):233-7. PubMed ID: 17087140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic impact of using alfuzosin 10 mg once daily in the management of acute urinary retention in the UK: a 6-month analysis.
    Annemans L; Cleemput I; Lamotte M; McNeill A; Hargreave T
    BJU Int; 2005 Sep; 96(4):566-71. PubMed ID: 16104911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.